Adimmune Corporation reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was TWD 753.34 million compared to TWD 617.72 million a year ago. Net income was TWD 160.98 million compared to TWD 160.34 million a year ago. Basic earnings per share from continuing operations was TWD 0.37 compared to TWD 0.38 a year ago. Diluted earnings per share from continuing operations was TWD 0.37 compared to TWD 0.38 a year ago. Basic earnings per share was TWD 0.37 compared to TWD 0.38 a year ago. Diluted earnings per share was TWD 0.37 compared to TWD 0.38 a year ago. For the nine months, sales was TWD 848.28 million compared to TWD 1,047.81 million a year ago. Net loss was TWD 251.8 million compared to net income of TWD 0.783 million a year ago. Basic loss per share from continuing operations was TWD 0.59. Diluted loss per share from continuing operations was TWD 0.59. Basic loss per share was TWD 0.59. Diluted loss per share was TWD 0.59.